Results 11 to 20 of about 33,530 (249)

Dynamic vascular changes in chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy

open access: yesPulmonary Circulation, 2020
Residual pulmonary hypertension is an important sequela after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Recurrent thrombosis or embolism could be a contributor to this residual pulmonary hypertension but the potential ...
Dieuwertje Ruigrok   +10 more
doaj   +2 more sources

Plasma metabolomic profile in chronic thromboembolic pulmonary hypertension

open access: yesPulmonary Circulation, 2020
We aimed to characterize the plasma metabolome of chronic thromboembolic pulmonary hypertension patients using a high-throughput unbiased omics approach.
Gustavo A. Heresi   +7 more
doaj   +2 more sources

Use of direct oral anticoagulants for chronic thromboembolic pulmonary hypertension

open access: yesClinics, 2018
OBJECTIVES: Chronic thromboembolic pulmonary hypertension is one of the most prevalent forms of pulmonary hypertension and is a major complication of acute pulmonary embolism.
Francisca Alexandra Gavilanes-Oleas   +9 more
doaj   +2 more sources

Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism [PDF]

open access: yesHaematologica, 2010
Background Chronic thromboembolic pulmonary hypertension after pulmonary embolism is associated with high morbidity and mortality. Understanding the incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism is important for ...
Frederikus A. Klok   +5 more
doaj   +2 more sources

Pulmonary arteriovenous malformation in chronic thromboembolic pulmonary hypertension

open access: yesIndian Journal of Radiology and Imaging, 2016
Chronic thromboembolic pulmonary hypertension is a morbid condition associated with complications such as hemoptysis, right heart failure, paradoxical embolism, and even death.
Arun Sharma   +3 more
doaj   +2 more sources

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry [PDF]

open access: yes, 2021
Objective: The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH ...
Vannucchi, V   +281 more
core   +2 more sources

Chronic thromboembolic pulmonary hypertension [PDF]

open access: yesNetherlands Heart Journal, 2015
We read with great interest the review by Scholzel et al. [1], about chronic thromboembolic pulmonary hypertension (CTEPH), and especially, the sections on pathophysiology, risk factors and diagnostic work-up. However, we would like a further comment about congenital abnormalities causing hypercoagulability in these subjects. In fact, in our experience
CORREALE, MICHELE   +5 more
openaire   +4 more sources

Optimizing the diagnosis and assessment of chronic thromboembolic pulmonary hypertension with advancing imaging modalities

open access: yesPulmonary Circulation, 2021
Imaging is key to nearly all aspects of chronic thromboembolic pulmonary hypertension including management for screening, assessing eligibility for pulmonary endarterectomy, and post-operative follow-up. While ventilation/perfusion scintigraphy, the gold
Seth Kligerman, Albert Hsiao
doaj   +1 more source

Case Report: Successful Concomitant Pulmonary Thromboendarterectomy and Carotid Endarterectomy

open access: yesFrontiers in Cardiovascular Medicine, 2022
Pulmonary thromboendarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension. Pulmonary thromboendarterectomy concomitant with additional cardiac procedures was reported as safe and feasible.
Zhan Liu   +9 more
doaj   +1 more source

Chronic thromboembolic pulmonary hypertension. [PDF]

open access: yesNetherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2006
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rapidly progressive and deadly disease, resulting from incomplete resolution of acute pulmonary embolism. Historically, the incidence of CTEPH was significantly underestimated but it may be as high as 3.8% following acute pulmonary embolism.
Reesink, H. J.   +2 more
  +8 more sources

Home - About - Disclaimer - Privacy